There are unmet needs.

Cigneon strives to address society's unmet medical needs by taking a novel approach to therapeutic development and delivery.

Learn More

INNOVATIONS

One of the First

fully-calculated Neurologic chimeric monoclonal antibodies.

An immediate solution

whenever opioids threaten.

Stop seizures

wherever they may seize.

Immediate countermeasures

for Carfentanil in the air.

Contact Us

Cigneon, LLC

111 N. Wabash Ave., Suite 100, Chicago, IL. 60602

Contact Investor Relations

invest@cigneon.com